Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13

Results For "Inke"

206 News Found

NHA announces revamped ABHA mobile application
News | May 24, 2022

NHA announces revamped ABHA mobile application

The revamped Ayushman Bharat Health Account (ABHA) mobile application offers added functionalities and a new User Interface (UI)


GeneQuantum Healthcare's two bioconjugate drugs approved for clinical trials in Australia
Biotech | May 16, 2022

GeneQuantum Healthcare's two bioconjugate drugs approved for clinical trials in Australia

They are GQ1005, an ADC with an excellent bystander killing effect, and GQ1007, a first-in-class antibody-immune-agonist-conjugate (AIAC) both with global intellectual property rights


Jawed Zia appointed CEO of Cadila Pharmaceuticals Domestic Prescription Business
People | May 14, 2022

Jawed Zia appointed CEO of Cadila Pharmaceuticals Domestic Prescription Business

A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business


Cipla posts consolidated PAT of Rs. 362.07 crore in Q4 FY2022
News | May 11, 2022

Cipla posts consolidated PAT of Rs. 362.07 crore in Q4 FY2022

Cipla has reported consolidated financial results for the period ended March 31, 2022


Gut microbiome as a tool in regenerative medicine
Biotech | May 07, 2022

Gut microbiome as a tool in regenerative medicine

Novel approach driven by GN Corp Japan with potentials in neurological illnesses


14.9 million excess deaths associated with the Covid-19 pandemic in 2020 and 2021
News | May 05, 2022

14.9 million excess deaths associated with the Covid-19 pandemic in 2020 and 2021

The report has estimated 4.74 million deaths for India in 2020 and 2021,


Wipro GE Healthcare launches locally made CT system
Healthcare | April 28, 2022

Wipro GE Healthcare launches locally made CT system

Revolution Aspire CT System is manufactured at the company’s new plant launched under the government’s Production Linked Incentives (PLI) Scheme


Sanofi continues to deliver strong business
News | April 28, 2022

Sanofi continues to deliver strong business

Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate


We continue to invest in R&D and new product development: Anish Bafna, CEO & MD, Healthium Medtech
interviews | April 22, 2022

We continue to invest in R&D and new product development: Anish Bafna, CEO & MD, Healthium Medtech

Healthium Medtech, a company focused on products used in surgical, post-surgical and chronic care has ramped up its play in the global healthcare industry. In an interview with Thomas C. Thottathil, Editor, Indian Pharma Post, Anish Bafna, CEO and MD, Healthium Medtech outlines his plans


PLI scheme to achieve Aatma Nirbhar Bharat: Dr Manshukh Mandaviya
News | April 17, 2022

PLI scheme to achieve Aatma Nirbhar Bharat: Dr Manshukh Mandaviya

The minister exhorted the pharmaceutical sector to prepare a plan for the next 25 years